NCT04952961

Brief Summary

Vulval cancer, while rare, has increased in incidence by 17% since the 1990s. It is strongly associated with age, thus this increasing trend is likely to continue with extended life expectancy. Vulval cancer is highly treatable when detected early. Women with chronic vulval conditions including lichen sclerosus, lichen planus and vulval intraepithelial neoplasia are at increased risk of developing vulval cancer. Most patients are in hospital follow-up, however regular vulval self-examination can pick up lesions earlier. There are no formalised methods of teaching self-examination and no evidence that it is acceptable to women. The main objective of this study is to pilot an intervention to promote and support vulval self-examination for women at increased risk of vulval cancer including those with lichen sclerosus, lichen planus and vulval intraepithelial neoplasia. Findings from this feasibility study will inform the design of a randomised trial comparing the interventions versus control with an embedded cost-effectiveness analysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 16, 2021

Completed
21 days until next milestone

First Posted

Study publicly available on registry

July 7, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

November 4, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 6, 2023

Completed
Last Updated

June 22, 2023

Status Verified

June 1, 2023

Enrollment Period

9 months

First QC Date

June 16, 2021

Last Update Submit

June 16, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in number of self-reported vulval self-examination events

    Change in number of self-reported vulval self-examination events over one month before and after the intervention. Patients are asked to record self-examination events in the patient diary

    6 months

Secondary Outcomes (4)

  • Change in Perceived Vulval Cancer Risk Score

    6 months

  • Change in Vulval Cancer Worry Scale

    6 months

  • Change in the Hospital anxiety and depression scale

    6 months

  • Vulval quality of life index

    6 months

Study Arms (1)

Single Arm Intervention

EXPERIMENTAL

Participants will be shown how to perform vulval self-examination in a face-to-face intervention and provided with an information leaflet. They will be sent reminders to self-examine each month.

Behavioral: Training in Vulval Self-Examination

Interventions

Face-to-face training in vulval self-examination Supplemented with use of aids ( hand mirror, mobile phone with selfie-stick), patient information leaflet, reminders to self-examine

Single Arm Intervention

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Prior diagnosis of a vulval condition with increased risk of malignancy ( lichen sclerosus, lichen planus or vulval intraepithelial neoplasia)
  • New diagnosis of a vulval condition with increased risk of malignancy ( lichen sclerosus, lichen planus or vulval intraepithelial neoplasia)
  • Must be able to provide informed consent

You may not qualify if:

  • Inability to consent or complete questionnaires due to cognitive or language issues
  • Inability of perform a vulval self-examination due to physical or visual impairments
  • Note: Those with physical or visual impairments can participate if a dyad is willing to learn how to perform a vulval examination

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Mary's Hospital, Manchester University Hospitals Foundation Trust

Manchester, United Kingdom

Location

MeSH Terms

Conditions

Self-ExaminationVulvar NeoplasmsVulvar Lichen SclerosusLichen Planus

Condition Hierarchy (Ancestors)

Health BehaviorBehaviorGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsVulvar DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesLichenoid EruptionsSkin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Vanitha Sivalingam, PhD

    University of Manchester

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Academic Clinical Lecturer in Gynaecological Oncology

Study Record Dates

First Submitted

June 16, 2021

First Posted

July 7, 2021

Study Start

November 4, 2021

Primary Completion

July 30, 2022

Study Completion

March 6, 2023

Last Updated

June 22, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations